Summary
Acute studies of clonidine suggest that it lowers blood pressure by central enhancement of baroreflex sensitivity coupled with diminished evidence of sympathetic outflow, but longterm clonidine data have not been conclusive. We examined effects of one month of low dose clonidine (0.4 ± 0.15 mg/day) alone in 13 essential hypertensive men, assessing several biochemical indices of sympathetic function, as well as physiologic parameters, including baroreflex sensitivity, the cold pressor test, and the hypotensive response to alpha adrenergic blockade. Clonidine diminished mean arterial pressure (from 104±5 to 84±3 mmHg;p<0.01), without associated changes in several biochemical parameters of sympathetic outflow (urinary excretion of catecholamines, metanephrines, and vanillylmandelic acid; allp>0.1). Circulatory baroreflex function was not enhanced by clonidine, during either the amylnitrite test or the phenylephrine test, before or after parasympathetic blockade with atropine. The cold pressor test, an index of efferent sympathetic pressor function, was also unaltered. The enhanced mean arterial pressure response to phentolamine during clonidine therapy (from a fall of 14.8±4.3 to 39.4±5.2 mmHg,p<0.01), suggested an increase in alpha adrenergic vascular tone, perhaps mediated by clonidine's alpha agonist properties in vascular smooth muscle. The antihypertensive mechanism of longterm low dose clonidine cannot reliably be ascribed either to baroreflex enhancement or to suppression of sympathetic outflow.
Similar content being viewed by others
References
Schmitt H, Schmitt H (1969) Localization of the hypotensive effect of 2-(2-6-dichlorophenyl-amino)-2-imidazole hydrochloride (St 155, catapresan). Eur J Clin Pharmacol 6: 8–12
Haeusler G (1974) Clonidine-induced inhibition of sympathetic nerve activity; no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch Pharmacol 286: 97–111
Van Zwieten PA (1973) The central action of antihypertensive drugs mediated via central α-receptors. J Pharm Pharmacol 25: 89–95
Hokfelt B, Hedeland H, Hansson B (1975) The effect of clonidine and penbutolol respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch Int Pharmacodyn Ther 213: 307–321
Wing L, Reid J, Hamilton C, Sever P, Davies DS, Dollery CT (1977) Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. Clin Sci Mol Med 53: 45–53
Metz S, Halter J, Porte D, Robertson (1978) Autonomic epilepsy: Clonidine blockade of paroxysmal catecholamine release and flushing. Ann Intern Med 88: 189–193
Sleight P, West MJ (1975) The effects of clonidine on the baroreflex arc in man. In: Davies DS, Reid JL (eds) Central action of drugs in blood pressure regulation. University Park Press, Baltimore
Tarazi RC, Dustan HP (1972) Beta adrenergic blockade in hypertension: practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol 29: 633–640
Johnson RH, Spalding JMK (1974) Disorders of the autonomic nervous system. Blackwell Scientific Publications, FA Davis Co., Philadelphia, PA, pp 1–22
Thomson PD, Melmon KL (1968) Clinical assessment of autonomic function. Anesthesiology 29: 724–731
Lilley JJ, Golden J, Stone RA (1976) Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 57: 1190–1200
Levy SB, Lilley JJ, Stone RA (1978) Baroreflex function in uremic and hypertensive man. Am J Med Sci 276: 57–66
Levy SB, Lilley JJ, Stone RA (1978) Circulatory reflex abnormalities in chronic renal failure: relationship to uremic hypertension. Cardiovasc Med 3: 675–682
Smyth HS, Sleight P, Pickering G (1969) Reflex regulation of arterial pressure during sleep in man: quantitative method of assessing baroreflex sensitivity. Circ Res 24: 109–121
Greene MA, Boltax AJ, Lustig GA, Rogow E (1965) Circulatory dynamics during the cold pressor test. Am J Cardiol 16: 54–60
Simon G, Kiowski W, Julius S (1978) Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol 22: 293–298
Jose AD, Taylor RR (1969) Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 48: 2019–2031
Esler M, Julius S, Zweifler, A, Randall O, Harburg E, Gardiner H, de Quattro V (1977) Mild high renin essential hypertension: neurogenic human hypertension? N Engl J Med 296: 405–411
Drayer JIM, Weber MA, Atlas SA, Laragh JH (1977) Phentolamine testing for alpha adrenergic participation in hypertensive patients: Independence from renin profiles. Clin Pharmacol Ther 22: 286–292
Esler MD, Julius S, Randall OS, Ellis CN, Kashima T (1975) Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol 36: 708–715
Hilliard CC, Bagwell EE, Daniell HB (1972) Effects of sympathetic and central nervous alterations on the blood pressure responses to phentolamine. J Pharmacol Exp Ther 180: 743–747
Crout JR, Pisano JJ, Sjoerdsma A (1961) Urinary excretion of catecholamines and their metabolites in pheochromocytoma. Am Heart J 61: 375–381
Pisano JJ, Crout JR, Abraham D (1962) Determination of 3-methoxy-4-hydroxy-mandelic acid in urine. Clin Chim Acta 7: 285
Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotension I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349–1355
Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein activity and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 60: 129–138
Bliss CI (1970) Statistics in biology. McGraw-Hill, New York, p 558
Hőkfelt B, Hedeland H, Dymling J-F (1970) Studies on catecholamines, renin, and aldosterone following catapresan (2-(2,6-dichlor-phenyl-amine)-2-imidazoline hydrochloride) in hypertensive patients. Eur J Pharmacol 10: 389–397
Reid JL, Wing LMH, Dargie HJ, Hamilton CA, Davies DS, Dollery CT (1977) Clonidine withdrawal in hypertension. Lancet 1: 1171–1174
Cavins S, Marshall A (1976) Clonidine withdrawal. Lancet 1: 368
Moore M, Phillipi P (1976) Clonidine overdose. Lancet 2: 694
Frolich J (1976) Symptoms of clonidine withdrawal after 17 days. N Engl J Med 295: 1261–1261
Yudkin J (1977) Withdrawal of clonidine. Lancet 1: 546
MacFaul R, Miller G (1977) Clonidine poisoning in children. Lancet 1: 1266–1267
Hansson L, Hunyor SN, Julius S, Hoobler SW (1973) Blood pressure crisis following withdrawal of clonidine (catapres, catapresan) with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J 85: 605–610
DeChamplain J (1977) The sympathetic system in hypertension. Clin Endocrinol Metab 6: 633–655
Reid IA, MacDonald DM, Pachnis B, Ganong WF (1975) Studies concerning the mechanism of suppression of renin secretion by clonidine. J Pharmacol Exp Ther 192: 713–721
Pettinger WA, Keeton TK, Campbell WB, Harper DC (1976) Evidence for a renal alpha adrenergic receptor inhibiting renin release. Circ Res 38: 338
Chevillard C, Pasquier R, Duchene N, Alexandre JM (1978) Mechanism of inhibition of renin release by clonidine in rats. Eur J Pharmacol 48: 451–454
Vandongen R, Greenwood DM (1975) The inhibition of renin secretion in the isolated rat kidney by clonidine hydrochloride (Catapres). Clin Exp Pharmacol Physiol 2: 583–588
Gribbin B, Pickering TG, Sleight P, Seto R (1971) Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29: 424–431
Takeshita A, Tanaka S, Kuriowa A, Nakamura M (1975) Reduced baroreceptor sensitivity in borderline hypertension. Circulation 51: 738–742
Haeusler G (1973) Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn Schmiedebergs Arch Pharmacol 278: 231–246
Mancia G, Ferrari A, Gregorini L, Zanchetti A (1979) Clonidine and carotid baroreflex in essential hypertension. Hypertension 1: 362–370
Pickering TG, Gribbin B, Petersen ES, Cunningham DJC, Sleight P (1972) Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res 30: 177–185
Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 39–100
Medgett IC, McCulloch MW, Rand MJ (1978) Partial agonist action of clonidine on prejunctional and postjunctional α-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 304: 215–221
Wing LMH, Reid JL, Davies DS, Dargie HJ, Dollery CT (1977) Apparent resistance to the hypotensive effect of clonidine. Br Med J 1: 136–138
Wilson IM, Freis ED (1959) Relationship between plasma and ecf volume depletion and the antihypertensive effect of chlorothiazide. Circulation 20: 1028–1036
Conway J, Lauwers P (1960) Hemodynamic and hypotensive effects of longterm therapy with chorothiazide. Circulation 21: 21–27
Lund-Johansen P (1974) Hemodynamic changes at rest and during exercise in longterm clonidine therapy of essential hypertension. Acta Med Scand 195: 111–115
Author information
Authors and Affiliations
Additional information
Supported by the Veterans Administration, and by a grant (HL-18095) from the National Institutes of Health Presented, in part, at the annual meeting of the Western Section, American Federation for Clinical Research, Carmel, CA, February, 1979. Clin. Res 27 (1): 15A, 1979
Rights and permissions
About this article
Cite this article
Cohen, I.M., O'Connor, D.T., Preston, R.A. et al. Long-term clonidine effects on autonomic function in essential hypertensive man. Eur J Clin Pharmacol 19, 25–32 (1981). https://doi.org/10.1007/BF00558378
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558378